SEC Form 4 · accession 0001209191-19-009840
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J Yeaman
Officer — President and CEO · Director
Period of report
Feb 11, 2019
Accepted (ET)
Feb 13, 2019 · 6:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Feb 11, 2019 | M | 948 | $28.24 | A | 33,843 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common StockF1 | Feb 11, 2019 | S | 948 | $62.8372 | D | 32,895 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common Stock | Feb 11, 2019 | M | 2,432 | $30.49 | A | 35,327 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common StockF2 | Feb 11, 2019 | S | 2,432 | $62.9743 | D | 32,895 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common StockF3 | holding | — | — | — | 109,664 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $28.24 | Feb 11, 2019 | M | 948 | D | — | Dec 15, 2021 | Class A Common Stock | 948 | 0 | I |
| Employee Stock Option (right to buy)F5 | $30.49 | Feb 11, 2019 | M | 2,432 | D | — | Dec 21, 2022 | Class A Common Stock | 2,432 | 231,968 | I |
Explanation of responses
- F1The shares were sold in multiple transactions at prices ranging from $62.72 to $62.93, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2The shares were sold in multiple transactions at prices ranging from $62.93 to $63.25, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3Shares held following the reported transactions include 109,664 restricted stock units, which are subject to forfeiture until they vest.
- F4This option was granted for a total of 260,605 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
- F5This option was granted for a total of 234,400 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
Remarks
**All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.**